Literature DB >> 7181484

In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections.

M J Ohm-Smith, W K Hadley, R L Sweet.   

Abstract

The in vitro activities of N-formimidoyl thienamycin, clindamycin, chloramphenicol, metronidazole, cefoperazone, cefotaxime, cefoxitin, moxalactam, penicillin G, and piperacillin were determined against 158 anaerobic bacteria isolated from endometrial wash cultures of women with pelvic infections. In general, N-formimidoyl thienamycin was the most active, with all organisms inhibited by less than or equal to 0.5 microgram/ml. Chloramphenicol, clindamycin, and metronidazole inhibited all organisms by less than or equal to 8 microgram/ml. The penicillins and cephalosporins exhibited variable activity of lesser degrees.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181484      PMCID: PMC183823          DOI: 10.1128/AAC.22.4.711

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.

Authors:  V A Tutlane; R V McCloskey; J A Trent
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

2.  Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.

Authors:  J H Jorgensen; S A Crawford; G A Alexander
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

3.  In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.

Authors:  M Nasu; J P Maskell; R J Williams; J D Williams
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

4.  Therapy of obstetrical infections with moxalactam.

Authors:  R S Gibbs; J D Blanco; Y S Castaneda; P J St Clair
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

5.  Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections.

Authors:  S A Gall; A P Kohan; O M Ayers; C E Hughes; W A Addison; G B Hill
Journal:  Obstet Gynecol       Date:  1981-01       Impact factor: 7.661

6.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

7.  In vitro activity of N-formimidoyl thienamycin (MK0787).

Authors:  F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

8.  Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections.

Authors:  R L Sweet; W J Ledger
Journal:  Obstet Gynecol       Date:  1979-08       Impact factor: 7.661

9.  In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.

Authors:  L Verbist; J Verhaegen
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

10.  Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies.

Authors:  F G Cunningham; D L Hemsell; R T DePalma; S Kappus; M Roark; B Nobles
Journal:  Am J Obstet Gynecol       Date:  1981-04-15       Impact factor: 8.661

View more
  8 in total

Review 1.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 2.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

3.  Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections.

Authors:  G B Hill; O M Ayers
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

4.  Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.

Authors:  J M Lacroix; F Lamothe; F Malouin
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

5.  In vitro activity of cefbuperazone and other antimicrobial agents against isolates from the female genital tract.

Authors:  M J Ohm-Smith; R L Sweet; W K Hadley
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

6.  Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.

Authors:  R J Zabransky; D G Bobey; A L Barry; S D Allen; P C Fuchs; E H Gerlach; C Thornsberry; W Sheikh; R N Jones
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

Review 7.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

8.  Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitals.

Authors:  I Brook
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.